Innovative Industrial Properties (IIPR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for June 11, 2025, at the company’s San Diego headquarters.
Shareholders are invited to vote on key proposals, including director elections, auditor ratification, and executive compensation.
Voting matters and shareholder proposals
Election of five directors to serve until the next annual meeting: Alan Gold, Gary Kreitzer, Scott Shoemaker, Paul Smithers, and David Boyle.
Ratification of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
Advisory vote on the compensation of named executive officers.
Additional business may be addressed if properly brought before the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Directors will serve until the next annual meeting and until successors are elected and qualified.
Latest events from Innovative Industrial Properties
- Tenant defaults led to lower Q1 results, but liquidity and tenant refresh efforts remain robust.IIPR
Q1 20258 Jul 2026 - Q2 revenue up 4% to $79.8M, net income $41.7M, AFFO $2.29/share, and dividend raised 4.4%.IIPR
Q2 20248 Jul 2026 - Q3 2024 revenue was $76.5M with 95.7% occupancy and strong liquidity despite industry headwinds.IIPR
Q3 20248 Jul 2026 - Q1 2026 revenue was $69M, but tenant defaults and debt maturity threaten ongoing viability.IIPR
Q1 20265 May 2026 - Diversified REIT with robust growth, strong balance sheet, and expanding life sciences exposure.IIPR
Investor presentation5 May 2026 - 2025 featured robust financials, strategic diversification, and strong governance ahead of key shareholder votes.IIPR
Proxy filing23 Apr 2026 - 2025 revenues hit $266M; life sciences investment and leasing drive growth amid tenant challenges.IIPR
Q4 202524 Feb 2026 - 2024 revenue steady at $308.5M; strong liquidity, high occupancy, and PharmaCann lease resolution.IIPR
Q4 202423 Dec 2025 - 2024 saw record revenue, strong governance, and enhanced ESG and compensation practices.IIPR
Proxy Filing1 Dec 2025